Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

被引：0
|
作者：
Cindy L. J. Weinstein
Alan G. Meehan
Jianxin Lin
Steven D. Briscoe
Marinella Govoni
机构：
[1] Merck & Co.,
[2] Inc,undefined
[3] MSD Italy,undefined
来源：
Clinical Rheumatology | 2023年 / 42卷
关键词：
Golimumab; TNF-α; Treatment persistence; Rheumatoid arthritis; Psoriatic arthritis; Ankylosing spondylitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3397 / 3405
页数：8
相关论文
共 50 条
  • [31] Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study
    Kavanaugh, Arthur
    McInnes, Iain B.
    Mease, Philip J.
    Krueger, Gerald G.
    Gladman, Dafna D.
    van der Heijde, Desiree
    Mudivarthy, Surekha
    Xu, Weichun
    Mack, Michael
    Xu, Zhenhua
    Beutler, Anna
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (11) : 1777 - 1785
  • [32] MALIGNANCIES WITH LONG-TERM USE OF IXEKIZUMAB IN ADULTS WITH PSORIASIS, PSORIATIC ARTHRITIS, OR AXIAL SPONDYLOARTHRITIS: A POSTHOC ANALYSIS OF DATA FROM 25 RANDOMIZED CLINICAL TRIALS
    Lebwohl, M.
    Deodhar, A.
    Blauvelt, A.
    Schwartzman, S.
    Feely, M.
    Kronbergs, A.
    Eberhart, N.
    Zhu, D.
    Inman, E.
    Holzkaemper, T.
    Rahman, P.
    Marzo-Ortega, H.
    Papp, K.
    Merola, J. F.
    Gottlieb, A. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1773 - 1774
  • [33] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: 5-YEAR DATA FROM THE SELECT-COMPARE STUDY
    Fleischmann, R. M.
    Swierkot, J.
    Penn, S.
    Durez, P.
    Bessette, L.
    Bu, X.
    Khan, N.
    Li, Y.
    Peterfy, C.
    Tanaka, Y.
    Mysler, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 725 - 726
  • [34] Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials
    Bergman, Martin
    Buch, Maya H.
    Tanaka, Yoshiya
    Citera, Gustavo
    Bahlas, Sami
    Wong, Ernest
    Song, Yanna
    Zueger, Patrick
    Ali, Mira
    Strand, Vibeke
    RHEUMATOLOGY AND THERAPY, 2022, 9 (06) : 1517 - 1529
  • [35] Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials
    Martin Bergman
    Maya H. Buch
    Yoshiya Tanaka
    Gustavo Citera
    Sami Bahlas
    Ernest Wong
    Yanna Song
    Patrick Zueger
    Mira Ali
    Vibeke Strand
    Rheumatology and Therapy, 2022, 9 : 1517 - 1529
  • [36] Long-term safety and effectiveness of adalimumab for the treatment of Japanese patients with rheumatoid arthritis: 3-year results from a postmarketing surveillance of 552 patients
    Harigai, Masayoshi
    Tsuchiya, Tsuyoshi
    Kawana, Katsuyoshi
    Kurimoto, Sarina
    MODERN RHEUMATOLOGY, 2018, 28 (01) : 30 - 38
  • [37] The incidence of arthropathy adverse events in efalizumab-treated patients is low and similar to placebo and does not increase with long-term treatment: pooled analysis of data from Phase III clinical trials of efalizumab
    Carlo Pincelli
    Eric Henninger
    Florence Casset-Semanaz
    Archives of Dermatological Research, 2007, 298 : 329 - 338
  • [38] The incidence of arthropathy adverse events in efalizumab-treated patients is low and similar to placebo and does not increase with long-term treatment: pooled analysis of data from Phase III clinical trials of efalizumab
    Pincelli, Carlo
    Henninger, Eric
    Casset-Semanaz, Florence
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2006, 298 (07) : 329 - 338
  • [39] LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: 3-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 1 STUDY
    Mcinnes, I.
    Kato, K.
    Magrey, M.
    Merola, J. F.
    Kishimoto, M.
    Haaland, D.
    Li, Y.
    Liu, Y.
    Liu, J.
    Lippe, R.
    Wung, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1137 - 1138
  • [40] Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials
    Atul Deodhar
    Andrew Blauvelt
    Mark Lebwohl
    Meghan Feely
    Andris Kronbergs
    Nadezhda Eberhart
    Danting Zhu
    Elsa Inman
    Elsie Grace
    Thorsten Holzkaemper
    Proton Rahman
    Helena Marzo-Ortega
    Kim A. Papp
    Joseph F. Merola
    Alice B. Gottlieb
    Sergio Schwartzman
    Arthritis Research & Therapy, 26
12345